UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Prognostic Factors in Primary Cutaneous B-Cell Lymphoma: The Italian Study Group for Cutaneous Lymphomas

Journal of clinical oncology, 2006-03, Vol.24 (9), p.1376-1382

2006

Volltextzugriff (PDF)

Rituximab Improves the Efficacy of High-Dose Chemotherapy With Autograft for High-Risk Follicular and Diffuse Large B-Cell Lymphoma: A Multicenter Gruppo Italiano Terapie Innnovative nei Linfomi Survey

Journal of clinical oncology, 2008-07, Vol.26 (19), p.3166-3175

2008

Volltextzugriff (PDF)

PCR-Detectable Nonneoplastic Bcl-2/IgH Rearrangements Are Common in Normal Subjects and Cancer Patients at Diagnosis but Rare in Subjects Treated With Chemotherapy

Journal of clinical oncology, 2003-04, Vol.21 (7), p.1398-1403

2003

Volltextzugriff (PDF)

Syringotropic mycosis fungoides: a rare variant of the disease with peculiar clinicopathologic features

The American journal of surgical pathology, 2011-01, Vol.35 (1), p.100-109

2011

Volltextzugriff (PDF)

Low-dose thalidomide plus dexamethasone is an effective salvage therapy for advanced myeloma

Haematologica (Roma), 2001-04, Vol.86 (4), p.399

2001

Volltextzugriff (PDF)

Ramipril-induced drug reaction with eosinophilia and systemic symptoms (DRESS)

EJD. European journal of dermatology, 2011-07, Vol.21 (4), p.624-625

2011

Volltextzugriff (PDF)

Dose-Intensive Melphalan With Stem Cell Support (MEL100) Is Superior to Standard Treatment in Elderly Myeloma Patients

Blood, 1999-08, Vol.94 (4), p.1248-1253

1999

Volltextzugriff (PDF)

Oral melphalan at diagnosis hampers adequate collection of peripheral blood progenitor cells in multiple myeloma

Haematologica (Roma), 2002-08, Vol.87 (8), p.846

2002

Volltextzugriff (PDF)

DIAGNOSIS, PROGNOSIS, AND STANDARD TREATMENT OF MULTIPLE MYELOMA

Hematology/oncology clinics of North America, 1997-02, Vol.11 (1), p.111-131

1997

Volltextzugriff (PDF)

Qualitative and quantitative polymerase chain reaction detection of the residual myeloma cell contamination after positive selection of CD34+ cells with small‐ and large‐scale Miltenyi cell sorting system

British journal of haematology, 2002-06, Vol.117 (3), p.642-645

2002

Volltextzugriff (PDF)

Dose-intensive melphalan with stem cell support (CM regimen) is effective and well tolerated in elderly myeloma patients

Haematologica (Roma), 2000-05, Vol.85 (5), p.508

2000

Volltextzugriff (PDF)

Multiple myeloma: ‘early’ plasma cell phenotype identifies patients with aggressive biological and clinical characteristics

British journal of haematology, 1993-11, Vol.85 (3), p.504-513

1993

Volltextzugriff (PDF)

Results of a low aggressivity chemotherapy regimen (CVP/CEB) in elderly Hodgkin's disease patients

Haematologica (Roma), 1996-09, Vol.81 (5), p.450

1996

Volltextzugriff (PDF)

Multiple myeloma: reduced plasma cell contamination in peripheral blood progenitor cell collections performed after repeated high‐dose chemotherapy courses

British journal of haematology, 1997-12, Vol.99 (3), p.685-691

1997

Volltextzugriff (PDF)

Multiple myeloma : increased circulating lymphocytes carrying plasma cell-associated antigens as and indicator of poor survival

Blood, 1990-10, Vol.76 (7), p.1375-1379

1990

Volltextzugriff (PDF)

Conventional induction treatments do not influence overall survival in multiple myeloma

British journal of haematology, 1997-02, Vol.96 (2), p.333-337

1997

Volltextzugriff (PDF)

Detection of Hyperreactive T Cells in Multiple Myeloma by Multivalent Cross-Linking of the CD3/TCR Complex

Blood, 1991-10, Vol.78 (7), p.1770-1780

1991

Volltextzugriff (PDF)

Expansion of T cells expressing low CD4 or CD8 levels in B-cell chronic lymphocytic leukemia : correlation with disease status and neoplastic phenotype

Blood, 1994-04, Vol.83 (8), p.2198-2205

1994

Volltextzugriff (PDF)

Combined differentiating therapy for myelodysplastic syndromes: A phase II study

Leukemia research, 1996-10, Vol.20 (10), p.867-876

1996

Volltextzugriff (PDF)

Idiotype vaccination in human myeloma : Generation of tumor-specific immune responses after high-dose chemotherapy

Blood, 1999-07, Vol.94 (2), p.673-683

1999

Volltextzugriff (PDF)

Multiple independent immunoglobulin class‐switch recombinations occurring within the same clone in myeloma

British journal of haematology, 1992-12, Vol.82 (4), p.676-680

1992

Volltextzugriff (PDF)

MACOP-B treatment in diffuse large-cell lymphoma: identification of prognostic groups in an Italian multicenter study

Journal of clinical oncology, 1992-02, Vol.10 (2), p.219-227

1992

Volltextzugriff (PDF)

Suppression of in vitro maintenance of non-promyelocytic myeloid leukemia clonogenic cells by all- trans retinoic acid: Modulating effects of dihydroxylated vitamin D3, α interferon and ‘stem cell factor’

Leukemia research, 1997, Vol.21 (1), p.51-58

1997

Volltextzugriff (PDF)

Interferon plus glucocorticoids as intensified maintenance therapy prolongs tumor control in relapsed myeloma

Acta haematologica, 1993-01, Vol.90 (2), p.71-76

1993

Volltextzugriff (PDF)

1 – 25 von 36

Suche als RSS-Feed

Aktive Filter

ThemaAged

ThemaBiological And Medical Sciences

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(36)
Mit Volltextzugriff
(24)

Publikationsform

Artikel
(36)

Sprache

Englisch
(36)

Erscheinungsjahr

n.n

Thema

Humans
(36)
Medical Sciences
(36)
Life Sciences & Biomedicine
(33)
Science & Technology
(33)
Middle Aged
(31)
Female
(26)
Male
(25)
Hematology
(20)
Adult
(18)
Hematologic And Hematopoietic Diseases
(16)
Aged, 80 And Over
(14)
Antineoplastic Agents
(14)
Pharmacology. Drug Treatments
(14)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(13)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(13)
Oncology
(12)
Prognosis
(11)
Treatment Outcome
(11)

13 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Prognostic Factors in Primary Cutaneous B-Cell Lymphoma: The Italian Study Group for Cutaneous Lymphomas

Rituximab Improves the Efficacy of High-Dose Chemotherapy With Autograft for High-Risk Follicular and Diffuse Large B-Cell Lymphoma: A Multicenter Gruppo Italiano Terapie Innnovative nei Linfomi Survey

PCR-Detectable Nonneoplastic Bcl-2/IgH Rearrangements Are Common in Normal Subjects and Cancer Patients at Diagnosis but Rare in Subjects Treated With Chemotherapy

Syringotropic mycosis fungoides: a rare variant of the disease with peculiar clinicopathologic features

Low-dose thalidomide plus dexamethasone is an effective salvage therapy for advanced myeloma

Reduced-intensity conditioning followed by allografting of hematopoietic cells can produce clinical and molecular remissions in patients with poor-risk hematologic malignancies

Ramipril-induced drug reaction with eosinophilia and systemic symptoms (DRESS)

Dose-Intensive Melphalan With Stem Cell Support (MEL100) Is Superior to Standard Treatment in Elderly Myeloma Patients

Oral melphalan at diagnosis hampers adequate collection of peripheral blood progenitor cells in multiple myeloma

DIAGNOSIS, PROGNOSIS, AND STANDARD TREATMENT OF MULTIPLE MYELOMA

Qualitative and quantitative polymerase chain reaction detection of the residual myeloma cell contamination after positive selection of CD34+ cells with small‐ and large‐scale Miltenyi cell sorting system

Dose-intensive melphalan with stem cell support (CM regimen) is effective and well tolerated in elderly myeloma patients

Multiple myeloma: ‘early’ plasma cell phenotype identifies patients with aggressive biological and clinical characteristics

Results of a low aggressivity chemotherapy regimen (CVP/CEB) in elderly Hodgkin's disease patients

Multiple myeloma: reduced plasma cell contamination in peripheral blood progenitor cell collections performed after repeated high‐dose chemotherapy courses

Multiple myeloma : increased circulating lymphocytes carrying plasma cell-associated antigens as and indicator of poor survival

Conventional induction treatments do not influence overall survival in multiple myeloma

Detection of Hyperreactive T Cells in Multiple Myeloma by Multivalent Cross-Linking of the CD3/TCR Complex

Expansion of T cells expressing low CD4 or CD8 levels in B-cell chronic lymphocytic leukemia : correlation with disease status and neoplastic phenotype

Combined differentiating therapy for myelodysplastic syndromes: A phase II study

Idiotype vaccination in human myeloma : Generation of tumor-specific immune responses after high-dose chemotherapy

Multiple independent immunoglobulin class‐switch recombinations occurring within the same clone in myeloma

MACOP-B treatment in diffuse large-cell lymphoma: identification of prognostic groups in an Italian multicenter study

Suppression of in vitro maintenance of non-promyelocytic myeloid leukemia clonogenic cells by all- trans retinoic acid: Modulating effects of dihydroxylated vitamin D3, α interferon and ‘stem cell factor’

Interferon plus glucocorticoids as intensified maintenance therapy prolongs tumor control in relapsed myeloma

Aktive Filter

Suchergebnisse filtern